Phase 3 Study Supports Efficacy, Safety of New Chemical Entity for ... - Psychiatric Times

Submitted by Anonymous (not verified) on Wed, 09/20/2023 - 18:52

Phase 3 Study Supports Efficacy, Safety of New Chemical Entity for ...  Psychiatric Times